Grandal, B.; Aljehani, A.; Dumas, E.; Daoud, E.; Jochum, F.; Gougis, P.; Hotton, J.; Lemoine, A.; Michel, S.; Laas, E.;
et al. No Impact of Seasonality of Diagnoses on Baseline Tumor Immune Infiltration, Response to Treatment, and Prognosis in BC Patients Treated with NAC. Cancers 2022, 14, 3080.
https://doi.org/10.3390/cancers14133080
AMA Style
Grandal B, Aljehani A, Dumas E, Daoud E, Jochum F, Gougis P, Hotton J, Lemoine A, Michel S, Laas E,
et al. No Impact of Seasonality of Diagnoses on Baseline Tumor Immune Infiltration, Response to Treatment, and Prognosis in BC Patients Treated with NAC. Cancers. 2022; 14(13):3080.
https://doi.org/10.3390/cancers14133080
Chicago/Turabian Style
Grandal, Beatriz, Ashwaq Aljehani, Elise Dumas, Eric Daoud, Floriane Jochum, Paul Gougis, Judicaël Hotton, Amélie Lemoine, Sophie Michel, Enora Laas,
and et al. 2022. "No Impact of Seasonality of Diagnoses on Baseline Tumor Immune Infiltration, Response to Treatment, and Prognosis in BC Patients Treated with NAC" Cancers 14, no. 13: 3080.
https://doi.org/10.3390/cancers14133080
APA Style
Grandal, B., Aljehani, A., Dumas, E., Daoud, E., Jochum, F., Gougis, P., Hotton, J., Lemoine, A., Michel, S., Laas, E., Laé, M., Pierga, J.-Y., Alaoui Ismaili, K., Lerebours, F., Reyal, F., & Hamy, A. S.
(2022). No Impact of Seasonality of Diagnoses on Baseline Tumor Immune Infiltration, Response to Treatment, and Prognosis in BC Patients Treated with NAC. Cancers, 14(13), 3080.
https://doi.org/10.3390/cancers14133080
